TF and neoplasm: Upon administration to tumor spheroids, CNT-DOX-Fe3O4-Tf and CNT-DOX-Fe3O4-mAb nanobots were significantly more efficacious in tumor reduction at 72 h than the control groups including free DOX and CNT-DOX-Fe3O4 nanobot.